Prevalence of sarcopenia in patients with chronic heart failure and chronic kidney disease
- Authors: Sokolova A.V.1,2, Dragunov D.O.1,2, Arutyunov G.P.3
-
Affiliations:
- Pirogov Russian National Research Medical
- Research Institute of Healthcare Organization and Medical Management of the Moscow Healthcare Department
- Pirogov Russian National Research Medical University
- Issue: Vol 15, No 3 (2023)
- Pages: 18-23
- Section: Original Articles
- URL: https://journals.rcsi.science/2075-3594/article/view/275317
- DOI: https://doi.org/10.18565/nephrology.2023.3.18-23
- ID: 275317
Cite item
Open Access
Access granted
Subscription Access
Abstract
Objective. Evaluation of the prevalence of sarcopenia in patients with CKD and CHF.
Materials and methods. The analysis included 107 patients with an established diagnosis of CHF, mean age was 69.6±11.3 years. All patients underwent screening for sarcopenia and CKD in accordance with the recommendations. For statistical analysis of the obtained data, the R language and RStudio software were used.
Results. CKD was detected in 105 patients with CHF: 32 patients had C2, 31 patients had C3a, 32 patients had C3b, 4 patients had C4 (CKD4), and only 2 patients did not have CKD. The largest number of CHF decompensation was detected in patients with CKD3b and CKD4. Presarcopenia was detected in 39% of patients with CHF and CKD, and sarcopenia in 38%. According to multivariate regression analysis, the risk of sarcopenia was most influenced by fat mass OR 1.14, 95% CI [1.01;1.34], P=0.057, muscle mass index OR 0.61, 95% CI [0.42 ;0.79], P=0.002 and male gender OR 1.17, 95% CI [60.9;85.77], P<0.001.
Conclusion. In patients with CHF and CKD, the increase in sarcopenia occurs as the filtration function of the kidneys decreases.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Anna V. Sokolova
Pirogov Russian National Research Medical; Research Institute of Healthcare Organization and Medical Management of the Moscow Healthcare Department
Author for correspondence.
Email: tamops2211@gmail.com
Cand.Sci. (Med.), Associate Professor, Associate Professor at the Department of Propaedeutics of Internal Diseases, Faculty of Pediatrics, Leading Specialist at the Organizational and Methodological Department for Therapy
Russian Federation, 4 Startovaya st., Moscow; MoscowDmitry O. Dragunov
Pirogov Russian National Research Medical; Research Institute of Healthcare Organization and Medical Management of the Moscow Healthcare Department
Email: tamops2211@gmail.com
Cand.Sci. (Med.), Associate Professor, Associate Professor at the Department of Propaedeutics of Internal Diseases, Faculty of Pediatrics, Head of the Organizational and Methodological Department for Therapy
Russian Federation, 4 Startovaya st., Moscow; MoscowGrigory P. Arutyunov
Pirogov Russian National Research Medical University
Email: tamops2211@gmail.com
Dr.Sci. (Med.), Professor, Corresponding Member of RAS, Head of the Department of Propaedeutics of Internal Diseases, Faculty of Pediatrics
Russian Federation, 4 Startovaya st., MoscowReferences
- Kim D.W., Song S.H. Sarcopenia in chronic kidney disease: From bench to bedside. Korean J. Intern. Med. [Internet]. 2023;38:303–21. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175867.
- Sabatino A., Cuppari L., Stenvinkel P., et al. Sarcopenia in chronic kidney disease: What have we learned so far? J. Nephrol. [Internet]. 2021;34:1347–72. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357704.
- Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., et al. Sarcopenia: European consensus on definition and diagnosis. Age and Ageing. [Internet]. 2010;39:412–23. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886201.
- Cruz-Jentoft A.J., Bahat G., Bauer J., et al. Sarcopenia: Revised european consensus on definition and diagnosis. Age and Ageing [Internet]. 2019;48:16–31. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322506.
- Zuo X., Li X., Tang K., et al. Sarcopenia and cardiovascular diseases: A systematic review and meta-analysis. J. Cachex. Sarcopen. Muscle [Internet]. 2023;14:1183–98. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235887.
- Редакционная С. Клинические рекомендации. Хроническая болезнь почек (ХБП). Нефрология [Internet]. 2021;25:10–82. Available from: https://journal.nephrolog.ru/jour/article/view/2024.
- Wang X.H., Mitch W.E. Mechanisms of muscle wasting in chronic kidney disease. Nat. Rev. Nephrol. [Internet]. 2014;10:504–16. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269363.
- Liu X., Chen S., Liu C., et al. Novel risk-factor analysis and risk-evaluation model of falls in patients receiving maintenance hemodialysis. Renal Failure [Internet]. 45:2182608. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980417/.
- Matabuena M., Abdalla P.P., Machado D.R.L., et al. Handgrip strength conditional tolerance regions suggest the need for personalized sarcopenia definition: an analysis of the American NHANES database. Aging Clin. Exp. Res. 2023;35:1369–73.
- Соколова А.В., Драгунов Д.О., Арутюнов Г.П., et al. Прогностическое значение саркопении у пациентов с ХБП. Клин. нефрология [Internet]. 2019; Available from: https://www.elibrary.ru/item.asp?id=37729264.
Supplementary files
